首页 | 本学科首页   官方微博 | 高级检索  
     

肿瘤分子核医学的进展
引用本文:吴靖川. 肿瘤分子核医学的进展[J]. 上海交通大学学报(医学版), 2005, 25(12): 1205-1208
作者姓名:吴靖川
作者单位:上海第二医科大学,新华医院核医学科,上海,200092;上海第二医科大学,临床核医学研究所,上海,200092
摘    要:该文综述了正电子、单光子核素肿瘤示踪剂的发展、肿瘤细胞摄取的分子学基础以及今后的研究方向。随着正电子核素标记物的广泛应用,对价格低、适应我国国情的符合电路SPECT和高档次PET/CT的发展作了比较。在临床应用中,重点介绍^18F—FDG显像在甲状腺癌、肺癌、淋巴瘤以及乳腺癌的早期诊断、分期、疗效、预后以及在今后放射治疗中的应用。

关 键 词:肿瘤  分子核医学  正电子  单光子  符合电路SPECT  PET/CT
文章编号:0258-5898(2005)12-1205-04
修稿时间:2005-08-20

Advances of Molecular Nuclear Medicine in Oncology
WU Jing-chuan. Advances of Molecular Nuclear Medicine in Oncology[J]. Journal of Shanghai Jiaotong University:Medical Science, 2005, 25(12): 1205-1208
Authors:WU Jing-chuan
Affiliation:WU Jing-chuan~
Abstract:The article summarized the advances of positron and single photon radiopharmceuticals in oncology, the molecular mechanism of tumor cell uptake and ongoing research strategy in future. With the widely used positron labeled compounds,a comparison was made between the dual-head-coincidence SPECT/CT, low price available in China, and the delicate PET/CT. In clinical application the early diagnosis, staging, therapeutic monitoring, prognosis and radiotherapeutic use in thyroid carcinoma, lung cancer, lymphoma and breast cancer of ~(18)F-FDG imaging was emphasized.
Keywords:tumor  molecular nuclear medicine  positron  single photon  coincident SPECT  PET/CT
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号